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Abstract 
The paper examines 32855 papers published on liposome research during the years 2011−20, as listed 
in the Scopus database. The global publication output on liposome research increased from 2907 in 
2011 to 3695 in 2020 with average annual growth of 2.76%. The United States was the most productive 
country in liposome research followed by China and India. The maximum number of papers on 
liposome research were published by researchers from the Ministry of Education China (640 
publications), CNRS (550 publications), and the Chinese Academy of Sciences (454 publications). 
Biochemistry, Genetics and Molecular Biology account for the largest number of publications in 
liposome research. Journal of Controlled Release published the maximum number of publications on 
liposome research during this period. Hideyoshi Harashima from Hokkaido University, Japan was a 
leading author in liposome research with the maximum number of publications.  
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1. Introduction 
The liposomes are an important nano-sized drug delivery system with distinct properties, such as ease 
of preparation, characteristic bilayer structure, and excellent biocompatibility (Bozzuto & Molinari, 
2015; Li et al., 2019). A substantial attempt has been done over the last several decades to develop 
liposome-based drug delivery systems. Several drugs have been encapsulated in liposomes 
to reduce toxicity and to extend the duration of the therapeutic effect (Alavi et al., 2017; Sharma et al., 
2020). Various liposomal-based systems have been approved by the FDA and are undergoing clinical 
trials involving a broad range of anti-cancer, anti-viral, and anti-bacterial applications (Crommelin et 
al., 2020; L. Liu et al., 2019; Tahara et al., 2018). Further advances in the optimization of liposome-
based drug delivery systems using various preparation techniques and an expanded application to new 
modalities such as nucleic acid therapy, immunotherapy, CRISPR/Cas9 therapeutic approaches have 
also been investigated to meet the continued demands for new drugs in the clinic (Gao et al., 2019; Zhen 
& Li, 2020). In recent years, several functionalities have also been introduced to liposomes, including 
in vivo imaging probes, temperature and ph-sensitive moieties, and novel agents for photothermal and 
photodynamic therapies (Belfiore et al., 2018; Lamichhane et al., 2018). 
 
In recent years, scientometrics and bibliometrics have been widely applied in various fields to identify 
the productivity of authors, institutions, and countries, international collaborations, and to identify the 
research trends in a specific subject area (Sharma, 2019; Sharma et al., 2019; M. H. Wang et al., 2011). 
Although the interest in liposome research has been increasing, very few studies were carried out from 
a global perspective for measuring and analyzing scientific publications on liposome research. Zhou et 
al. performed a bibliometric analysis of global liposome research during 1995–2014 using data retrieved 
from the Web of Science database (Zhou & Zhao, 2015). The present study aims to analyze the 
publication growth rate, most productive subject areas, recent research trends, leading countries, top 
funding agencies, top organizations, most prolific authors, and most productive journals publishing 
research in the subject based on the data exported from SCOPUS database. SCOPUS is regarded as 
one of the largest databases of peer-reviewed literature covering a broad variety of subjects (Boyle & 
Sherman, 2005). 
 
2. Materials and methods 
The publication data for the present study was exported from the SCOPUS database 
[https://www.SCOPUS.com]. A search was carried out in the SCOPUS database using the keyword 
‘‘Liposome’’ and results were filtered by publication year from 2011 through 2020. The complete 
metadata was exported to MS-excel in CSV format containing the citations and bibliometric 
information. The publication data was imported to SciVal [https://www.Scival.com] for further 
analysis. Several publication-quality indicators were employed to help identify publications and citation 
trends such as citations per paper (CPP), field weighted citation impact (FWCI), international 
collaborative papers (ICP), and h-index (Avanesova & Shamliyan, 2018; Sharma, 2021). The CPP is 
calculated by dividing the total number of citations by the total number of publications. The FWCI 
compares the total citations received by publications of an entity with the global average for the similar 
subject field, publication type, and publication year. The global average of the FWCI is taken as 1. 
International collaborative papers (%) represent the percentage of papers published with international 
co-authors. h-index was regarded as the h of Np articles were cited no less than h times each and the 
other (Np-h) articles were cited no more than h times each (Hirsch, 2005). >100 indicates the number 
of papers with more than 100 citations and >50 indicates the number of papers with more than 50 
citations. 
 
3. Analysis and results 
3.1 Characteristics of Publication Output 
The year-wise distribution of publication output revealed the progress of research on liposomes over 
time (Table 1, Figure 1). Global research output in liposome research consisted of 32855 publications 
during 2011-20 and registered an average annual growth rate of 2.76%. The articles published during 
2011-20 had an average citation per paper of 21.3 and international collaboration of 24%. The number 
of global scientific publications increased from 2907 in 2011 to 3695 in 2020. Of the total publications, 
75.05% (24659) appeared as articles, 17% (5586) as reviews, 3.01 % (990) as a book chapter, and 
2.31% (759) as conference papers. Other types of publications contributed less than 2.62% share.  
 
 
Figure 1. Global publication output in liposome research during 2011-20 
 
Table 1. Global publication output during 2011-20  
Year  TP AGR (%) TC CPP ICP (%) 
2011 2907 - 107401 36.9 20.7 
2012 3062 5.33 112319 36.7 21.6 
2013 3180 3.85 103123 32.4 20.4 
2014 3148 -1.01 92106 29.3 23.3 
2015 3134 -0.44 78795 25.1 23.2 
2016 3402 8.55 71717 21.1 24.7 
2017 3300 -3 56473 17.1 24.3 
2018 3428 3.88 42730 12.5 26 
2019 3599 4.99 26959 7.5 26.7 
2020 3695 2.67 7708 2.1 27.3 
2011-2015 15431 - 493744 32.0 21.9 
2016-2020 17424 - 205587 11.8 25.9 
2011-2020 32855 - 699331 21.3 24 
TP=Total publications; TC=Total citations; CPP=Citations per paper; ICP=International Collaborative Papers 
 
The subject areas (as defined by the SCOPUS database) were used as criteria for understanding the 
distribution of liposome research during 2011-20. Biochemistry, Genetics and Molecular Biology 
accounted for the largest publications share (40.8%), followed by Pharmacology, Toxicology and 
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Pharmaceutics (35.93%), Medicine (23.28%), Chemistry (22.87%), and Materials Science (17.32%). 
Among these subject areas, Chemical Engineering registered the highest citation per paper of 25.5, 
followed by Engineering (25.4), and Materials Science (25%). Subject-wise distribution of global 
publication output in liposome research during 2011-20 is shown in Table 2. 
Table 2. Subject-wise distribution of Indian publications in liposome research during 2011-20  
S. 
No. 
Subject TP % TP TC CPP 
1 Biochemistry, Genetics and Molecular 
Biology  
13391 40.76 288936 21.6 
2 Pharmacology, Toxicology and 
Pharmaceutics  
11806 35.93 283430 24.0 
3 Medicine  7648 23.28 142336 18.6 
4 Chemistry  7513 22.87 152498 20.3 
5 Materials Science  5691 17.32 142102 25.0 
6 Chemical Engineering  5343 16.26 136444 25.5 
7 Engineering  4070 12.39 103251 25.4 
8 Physics and Astronomy  3139 9.55 67180 21.4 
9 Immunology and Microbiology  1939 5.90 41036 21.2 
10 Agricultural and Biological Sciences  1487 4.53 26874 18.1 
TP=Total publications; TC=Total citations; CPP=Citations per paper 
 
3.2 Most productive countries 
Publication data of the top 10 most productive countries in liposome research during 2011-20 is shown 
in Table 3 and Figure 2. The top 10 most productive countries contributed 85.66% share of global 
publication output. The United States tops the list with a global publication share of 21.6%. China ranks 
second (with a publication share of 19.41%), followed by India (8.05%), Japan (7.75%), Germany 
(6.23%). The United States had the highest h-index (178), followed by China (107), and Germany (92). 
The United Kingdom registered the highest citation per paper of 30.4 followed by Canada (28.6), and 
South Korea (27.1). The United Kingdom had the highest FWCI of 1.83. Researchers from the United 
Kingdom published the highest number of internationally collaborative papers (62.4%), followed by 
authors from Germany (60.7%) and France (57.6%). The United States produced the maximum number 
of highly cited papers with more than 100 and 50 citations. The proportion of self-citations was 
lowest in papers published by the United Kingdom (3.38%), while the proportion of self-citations was 
highest in papers published by China (10.4%).  
 
Figure 2. Top 10 most productive countries in liposome research during 2011-20 
 
Table 3. Publication data of top 10 most productive countries in liposome research during 2011-20 










7921 24.11 240708 6.94 30.4 1.79 39.6 426 1151 178 
2 China 6377 19.41 108610 10.44 17 1.35 20.7 124 470 107 
3 India 2645 8.05 45254 8.19 17.1 1.19 23.7 62 191 83 
4 Japan 2546 7.75 44914 9.50 17.6 1.1 22.5 47 160 77 
5 Germany 2048 6.23 51997 4.21 25.4 1.57 60.7 83 237 92 
6 Italy 1649 5.02 38346 8.62 23.3 1.66 46.6 38 189 78 
7 United 
Kingdom 
1509 4.59 40798 3.38 27 1.83 62.4 74 204 87 
8 France 1382 4.21 34070 4.38 24.7 1.59 57.6 52 174 79 
9 South 
Korea 
1043 3.17 28293 3.41 27.1 1.61 31.9 36 108 69 
10 Canada 1024 3.12 29278 4.07 28.6 1.6 51.1 40 122 71 
TP=Total publications; TC=Total citations; SC=Self citations; CPP=Citations per paper; FWCI= Field weighted citation impact, 
ICP=International Collaborative Papers; >100=Number of papers with more than 100 citations, >50= Number of papers with more than 50 
citations 
 
3.3 Journal Analysis 
The top 10 journals publishing papers in the liposome research during 2011-20 are shown in Table 4. 









































The top 10 most productive journals publishing articles in the field of liposome research during 2011-
2020 together contributed 5079 papers to global publication output with a publication share of 15.46%. 
Journal of Controlled Release had the highest publication output (857), followed by the International 
Journal of Pharmaceutics (763) and International Journal of Nanomedicine (142). Among these most 
productive journals, Biomaterials registered the highest citation per paper of 55.5, followed by Journal 
of Controlled Release (48.2), and International Journal of Nanomedicine (30.4). Journal of Controlled 
Release had the highest h-index of 93, followed by Biomaterials (75), and International Journal of 
Pharmaceutics (61). Journal of Controlled Release received the highest FWCI of 3.61 and published 
the maximum number of highly cited papers with more than 100 and 50 citatio.  
 
Table 4. Top 10 journals publishing papers in the liposome research during 2011-20 
S. 
No. 






1 Journal of Controlled 
Release  
857 41288 48.2 3.61 31.4 80 254 93 14.4 
2 International Journal of 
Pharmaceutics  
763 18258 23.9 2.61 26.9 16 89 61 7.6 
3 International Journal of 
Nanomedicine  
550 16715 30.4 1.51 21.3 25 69 57  7.1 
4 Biochimica Et 
Biophysica Acta 
Biomembranes  
519 9302 17.9 0.97 33.5 3 29 44 7.8 
5 Colloids and Surfaces B 
Biointerfaces  
499 9610 19.3 1.17 27.9 4 46 48 7.1 
6 Langmuir  481 8161 17 1.08 32.2 3 33 44 6.1 
7 Plos One  409 8008 19.6 0.95 30.4 2 27 42 5.2 
8 Biomaterials  365 20242 55.5 2.85 29.3 43 145 75 18.7 
9 Journal of Liposome 
Research  
341 3833 11.2 1.2 17.6 0 8 27 4.1 
10 Scientific Reports  295 4539 15.4 0.86 36.1 4 14 31 7.2 
TP=Total publications; TC=Total Citations; CPP=Citations per paper; FWCI= Field weighted citation impact, ICP=International collaborative 
papers; >100=Number of papers with more than 100 citations, >50= Number of papers with more than 50 citations 
 
3.4 Top 10 funding agencies 
The top 10 funding agencies in liposome research are shown in Figure 3. National Natural Science 
Foundation of China funded 2367 publications during 2011-20 and stands first followed by National 
Institutes of Health (1863 publications), Department of Japan Society for the Promotion of Science 
(1466 publications), National Cancer Institute (1092), and National Institute of General Medical 
Sciences (1030 publications). Table 4 shows the top ten funding agencies that are financially assisting 
research activities in the field of liposome research. 
 
 
Figure 3. Top 10 funding agencies in liposome research 
 
3.5 Contribution and impact of most productive organizations 
The research performance of the top 15 most productive global organizations in the field of 
liposome research during 2011-20 is given in Table 5. These 15 organizations account for 
14.49% (4761 publications) of total global publication output. Ministry of Education China (640 
publications) was the most productive organization followed by CNRS (550 publications), and 
the Chinese Academy of Sciences (454 publications). Harvard University registered the highest 
citation per publication of 53.5, followed by Utrecht University (44), and the Chinese Academy 
of Sciences (31.2). The average citation per paper of these 15 organizations was 24.4. Chinese 
Academy of Sciences and CNRS registered the highest h-index (57 each). The University of 
Copenhagen published the highest number of papers with international collaboration (63.5%), 
followed by Utrecht University (62.4%), and Harvard University (55.6%). Utrecht University 
recorded the highest FWCI of 3.2. Chinese Academy of Sciences produced the highest number of 
highly cited papers with more than 100 and 50 citations. 
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1 Ministry of Education China 640 10793 16.9 1.6 22 9 42 48 
2 CNRS  550 12693 23.1 1.48 53.6 18 65 57 
3 Chinese Academy of Sciences 454 14160 31.2 2.19 26.9 27 67 57 
4 Sichuan University 359 7015 19.5 1.69 12.8 8 31 43 
5 Harvard University 306 16356 53.5 3 55.6 20 45 48 
6 Inserm 284 5920 20.8 1.49 44.4 7 29 39 
7 National Research Council of 
Italy 
282 6247 22.2 1.36 38.3 7 24 37 
8 Universidade de Sao Paulo 278 4480 16.1 1.08 39.9 4 20 34 
9 University of Copenhagen 255 6453 25.3 1.57 63.5 8 36 44 
10 Shenyang Pharmaceutical 
University 
236 4778 20.2 1.86 12.7 4 15 36 
11 Utrecht University 234 10292 44 3.2 62.4 20 45 48 
12 Peking University 225 6754 30 2.02 14.7 12 45 48 
13 Osaka University 224 3199 14.3 0.98 16.5 2 16 30 
14 China Pharmaceutical 
University 
219 4504 20.6 1.79 23.7 7 16 34 
15 Russian Academy of Sciences 215 1874 8.7 0.74 29.3 0 2 23 
TP=Total publications; TC=Total citations; CPP=Citations per paper; FWCI= Field weighted citation impact, ICP=International Collaborative 
Papers; >100=Number of papers with more than 100 citations, >50= Number of papers with more than 50 citations 
 
3.6 Most prolific authors 
The Scientific productivity of the top authors on liposome research during 2011-20 is presented in 
Table 6. The 10 most productive authors together contributed 841 papers and generated 27652 
citations during 2011-20. Of the top ten contributing authors, Hideyoshi Harashima was the most 
productive author with 133 publications. Gert A. Storm was in second place with 115 publications 
followed by Mahmoud Reza Jaafari with 112 publications. Vladimir P. Torchilin registered the 
highest citation per publication of 73.3 among these authors, followed by Qiang Zhang (49.3), 
and Gert A. Storm (46.9). Gert A. Storm received the highest h-index of 37, followed by 
Vladimir P. Torchilin (33), and Hideyoshi Harashima (32). Robert Jian Guang Lee published 
the highest number of internationally collaborative papers (83.8%). Vladimir P. Torchilin and 
Zhirong Zhang registered the highest FWCI of 2.98. Vladimir P. Torchilin published the maximum 
number of highly cited papers with more than 100 and 50 citations. 
 
Table 6. Top 10 authors in the field of liposome research during 2011-20 
S. 
No. 








133 3875 29.1 2.12 9.8 6 22 32 
2 Gert A. 
Storm 











112 1617 14.4 1.52 18.8 0 3 26 





81 5938 73.3 2.98 34.6 15 25 33 
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63 1979 31.4 2.69 77.8 1 15 28 
11 Ryo Suzuki Teikyo 
University, Japan 





62 569 9.2 0.61 8.1 0 1 12 






61 754 12.4 1.26 31.2 0 1 16 
14 Qin He  Sichuan 
University, China 
61 2023 33.2 2.82 3.3 3 12 28 
15 Qiang Zhang  Peking 
University, China 
61 3005 49.3 2.84 6.6 7 20 30 
TP=Total publications; TC=Total Citations; CPP=Citations per paper; FWCI= Field weighted citation impact, ICP=International collaborative 
papers; >100=Number of papers with more than 100 citations, >50= Number of papers with more than 50 citations 
 
3.7 Recent research trends in liposome research  
SciVal analysis tool by Elsevier was used to identify the top keyphrases and most popular topics in 
liposome research. The period 2015–2020 was chosen to explore key areas that have been a major focus 
of researchers in recent years. Only original articles were included for the analysis. Keyphrases provide 
a reasonable description of a publication’s theme and could reveal the profile of an author’s research 
preferences (Rabby et al., 2018). Table 7 shows the top 20 most frequently occurring keyphrases used 
in publications related to liposome research during 2015-2020. Liposome, vesicle, drug delivery system, 
lipid bilayer, doxorubicin, lipid, bupivacaine, nanomedicine, phospholipid, nanocarrier, curcumin, 
phosphatidylcholine, gene transfer, small interfering RNA, membrane lipid, paclitaxel, targeted drug 
delivery, obstetric delivery, drug liberation, macrophage were the most frequently used keyphrases in 
liposome related research during 2015-2020. Word cloud of top keywords in liposome research during 
2015-2020 is presented in Figure 4. The Keyphrases such as theranostic medicine, photosensitizing 
agent, obstetric cancer, photodynamic therapy, controlled drug release, bupivacaine, liposomal 
doxorubicin, docetaxel, hyaluronic acid, nanoparticle, nanocarrier, extracellular vesicle, targeted drug 
delivery, targeting, microna, folic acid, permeation, prodrug, drug liberation, are gaining more 
popularity in recent publications in terms of publication growth. 
 
Table 7. Top 20 most frequently occurring keyphrases on liposome research during 2015-2020 
S. No. Keyphrase S. No. Keyphrase 
1 Liposome 11 Curcumin 
2 Vesicle 12 Phosphatidylcholine 
3 Drug Delivery System 13 Gene Transfer 
4 Lipid Bilayer 14 Small Interfering RNA 
5 Doxorubicin 15 Membrane Lipid 
6 Lipid 16 Paclitaxel 
7 Bupivacaine 17 Targeted Drug Delivery 
8 Nanomedicine 18 Obstetric Delivery 
9 Phospholipid 19 Drug Liberation 
10 Nanocarrier 20 Macrophage 
 
 
Figure 4. Word cloud of top keyphrases in liposome research during 2015-2020; keyphrase color 
legend: green – growing, blue – declining (Data source: SciVal) 
 
3.8 Highly cited articles 
The top 10 highly-cited research articles on liposome research during 2011-20 are shown in Table 8. 
“The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid 
bilayers” by Ashley C.E. et al. published in the year 2011 in the journal “Nature Materials” was the top-
cited article with a citation count of 779. Three more articles published during 2011-20 have received 
more than 500 citations so far. These include the articles titled “Inflammasome-activated gasdermin D 
causes pyroptosis by forming membrane pores” (published in Nature), “Mixed Lineage Kinase Domain-
like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3” (published 
in Molecular Cell), and “Pore-forming activity and structural autoinhibition of the gasdermin family” 
(published in Nature). These 10 most cited papers were published in 8 journals including 2 papers each 
in Nature and Nature Materials and 1 paper each in ACS Nano, Cell Reports, Molecular Cell, Nature 
Nanotechnology, Proceedings of the National Academy of Sciences of the United States of America, 
and The Lancet. 
 
Table 8. Highly cited research articles on liposome research during 2011-20 
S. 
No. 
Title Authors Year Journal Name Citations 
1 The targeted delivery of multicomponent 
cargos to cancer cells by nanoporous 
particle-supported lipid bilayers  
(Ashley et al., 
2011) 
2011 Nature Materials 779 
2 Inflammasome-activated gasdermin D 
causes pyroptosis by forming membrane 
pores  
(X. Liu et al., 
2016) 
2016 Nature 722 
3 Mixed Lineage Kinase Domain-like 
Protein MLKL Causes Necrotic 
Membrane Disruption upon 
Phosphorylation by RIP3  
(H. Wang et al., 
2014) 
2014 Molecular Cell 685 
4 Pore-forming activity and structural 
autoinhibition of the gasdermin family  
(Ding et al., 
2016) 
2016 Nature 585 
5 Nanoliposomal irinotecan with 
fluorouracil and folinic acid in metastatic 
pancreatic cancer after previous 
gemcitabine-based therapy (NAPOLI-1): 
A global, randomised, open-label, phase 
3 trial  
(Wang-Gillam 
et al., 2016) 
2016 The Lancet 458 
6 MLKL Compromises Plasma Membrane 
Integrity by Binding to 
Phosphatidylinositol Phosphates  
(Dondelinger et 
al., 2014) 
2014 Cell Reports 385 
7 Magneto-aerotactic bacteria deliver drug-
containing nanoliposomes to tumour 
hypoxic regions  





8 Interbilayer-crosslinked multilamellar 
vesicles as synthetic vaccines for potent 
humoral and cellular immune responses  
(Moon et al., 
2011) 
2011 Nature Materials 369 
9 Microtubule-associated protein 1 light 
chain 3 alpha (LC3)-associated 
phagocytosis is required for the efficient 
clearance of dead cells  
(Martinez et al., 
2011) 
2011 Proceedings of the 
National Academy 
of Sciences of the 
United States of 
America 
364 
10 Matrix metalloprotease 2-responsive 
multifunctional liposomal nanocarrier for 
enhanced tumor targeting  
(Zhu et al., 
2012) 
2012 ACS Nano 347 
 
4. Conclusion 
Due to their distinctive structural features, physiological characteristics, and biological properties, 
liposomes have gained significant attention among the scientific community. These drug delivery 
systems are promising platforms for targeting, drug delivery, imaging, diagnostics, and theranostics 
(Akbarzadeh et al., 2013; Xing et al., 2016). This work focuses on the scientometric analysis of 
liposome research literature from the year 2011 to 2020 with SCOPUS data source. The findings of the 
study show that research on liposomes is progressing in recent years. Researchers from the United 
States, China, and India Korea contributed the most to the publications. The USA and China were 
ranked first and second in terms of the quantity of publication outputs. The United States had the highest 
h-index, followed by China, and Germany. These influential countries foster international 
collaborations and published a large number of papers with an international co-authorship. China and 
India were the only developing countries among the top 10 most productive countries. Journal of 
Controlled Release published the highest number of papers on liposome research followed by the 
International Journal of Pharmaceutics and International Journal of Nanomedicine. The use of 
liposomes in drug delivery has already had a significant effect in a variety of biomedical fields. The 
FDA has approved over a dozen liposome-based drug delivery systems, and several more are in various 
stages of development. Because of their biocompatibility and biodegradability, liposomes are attracting 
a growing number of new applications in the pharmaceutical and food industries. Liposomes are used 
in a variety of applications, including diagnostics, drug and gene delivery, cosmetics, and food 
nanotechnology. Future research will be able to improve on existing platforms and overcome current 
translational and regulatory limitations by better understanding the difficulties and developments in 
liposomal technology. When compared to an approved counterpart or current therapies, the cost-benefit 
analysis can be a stumbling block to the clinical translation of certain liposomal-based therapies. A 
better understanding of lipid interactions, rapid formulation screening, and the use of techniques to 
maximize clinical compatibility would help liposomes perform better in future diagnostic and 
therapeutic applications. 
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